Loading
Cases by country, the UK and NHS pathway and other country lenses, and the expert centres with trials on record.
No country-level case numbers. This cancer is not mapped to a GLOBOCAN site.
| Taiwan | none recorded | 0 | 746 | 8,966 | - | ||
Guangzhou · hospital Programme: Guangdong Lung Cancer Institute | China | none recorded | 0 | 704 | 7,832 | - | |
Philadelphia, PA · hospital | United States | none recorded | 0 | 695 | 9,931 | - | |
| China | none recorded | 0 | 539 | 6,491 | - | ||
Aurora, CO · cancer center Programme: Oncogene-driven lung cancer, Lung cancer SPORE | United States | 0 | 483 | 13,480 | - | ||
Candiolo · cancer center | Italy | none recorded | 0 | 324 | 4,466 | - | |
Nashville, TN · cancer center | United States | 0 | 269 | 9,027 | - | ||
Ljubljana · cancer center | Slovenia | none recorded | 0 | 187 | 2,566 | - | |
Washington, DC · cancer center | United States | 0 | 100 | 2,434 | - | ||
Neu-Isenburg · consortium | Germany | none recorded | 0 | 94 | 1,947 | none recorded | - |
Chicago, IL · consortium | United States | none recorded | 0 | 42 | 482 | - | |
Tokyo · government | Japan | none recorded | 0 | not matched | - | - | |
Osaka · consortium | Japan | none recorded | 0 | not matched | - | - | |
Atlanta, GA · cancer center Programme: EGFR-mutant lung cancer (FLAURA) | United States | 0 | not matched | - | - |
These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with MET exon 14 and MET-amplified non-small-cell lung cancer but is thinly recorded here will look small.
Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.